Scopolamine hydrobromide hydrate/Methyl Salicylate/Camphor/Menthol

氢溴酸东莨菪碱/水杨酸甲酯/樟脑/薄荷脑

Report date: 2025/08/14 11:53:48

Base Information

Drug NameScopolamine hydrobromide hydrate/Methyl Salicylate/Camphor/Menthol
Drug Alias Name复方氢溴酸东莨菪碱贴膏
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor antagonistsTransient receptor potential cation channel subfamily M member 8 agonists
TargetsMuscarinic acetylcholine receptorTransient receptor potential cation channel subfamily M member 8
Therapy Area/IndicationsMotion Sickness
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Scopolamine hydrobromide hydrateMethyl SalicylateCamphor
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsMotion Sickness
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A